when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

by stage

Marketed
Phase 3
Phase 2
Phase 1
Preclinical

browse

Most catalysts
Recently active
All drugs →
Companies
Patent cliff

what

Trial readouts
PDUFA dates
Approvals
Earnings

when

Upcoming
Month grid
Recently passed

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News
Drugs
Calendar
Companies

Hubs

Topics
Patent cliff
Publications
Readouts

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

pharmadog
calendar
approval

approval

GLEEVEC (IMATINIB MESYLATE) — FDA approval

August 10, 2020$NVS Imatinib Mesylate Shilpaupdated 5mo ago

community read0 votes

Sponsor: NOVARTIS. Form: TABLET. Route: ORAL

view source ↗

Data sources

last refreshed 5mo ago

Found something off?

🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

drug timeline · 8

approvalGLEEVEC (IMATINIB MESYLATE) — FDA approvalJan 14, 2026 · 264d ago
approvalGLEEVEC (IMATINIB MESYLATE) — FDA approvalMar 1, 2024 · 948d ago
approvalGLEEVEC (IMATINIB MESYLATE) — FDA approvalAug 19, 2022 · 1508d ago
approvalGLEEVEC (IMATINIB MESYLATE) — FDA approvalMar 24, 2022 · 1656d ago
approvalGLEEVEC (IMATINIB MESYLATE) — FDA approvalAug 10, 2020 · 2247d ago
approvalGLEEVEC (IMATINIB MESYLATE) — FDA approvalAug 21, 2018 · 2967d ago
approvalGLEEVEC (IMATINIB MESYLATE) — FDA approvalSep 29, 2017 · 3293d ago
approvalGLEEVEC (IMATINIB MESYLATE) — FDA approvalSep 6, 2017 · 3316d ago

same company · ±60 days · 4

approvalImatinib Mesylate Shilpa: GLEEVEC (IMATINIB MESYLATE) — FDA approvalAug 10, 2020
approvalKESIMPTA: KESIMPTA (OFATUMUMAB) — FDA approvalAug 20, 2020
approvalSpexotras: MEKINIST (TRAMETINIB DIMETHYL SULFOXIDE) — FDA approvalJun 23, 2020
approvalCOSENTYX (SECUKINUMAB) — FDA approvalJun 16, 2020

🐶 often sniffed alongside

top 5

tagApproval106 co-mentions · 53 sources
drugGLEEVEC99 co-mentions · 53 sources
drugimatinib mesylate99 co-mentions · 53 sources
drugImatinib Mesylate CSPC53 co-mentions · 53 sources
tagSmall Molecule53 co-mentions · 53 sources

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?